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1. Introduction 
It was shown that cow’s milk contains a minor pro- 
tein that binds folic acid [l-3] and most of its deriv- 
atives [3-51. This protein was recently purified by af- 
finity chromatography, using Sepharose-bound folic 
acid [6]. There seems to be a growing interest in the 
folate binding protein, e.g. it was recently employed 
to determine folates in human serum [7-91. The 
present communication describes the synthesis of an 
insoluble preparation of the folate-binding protein 
and discusses some of its potential uses. 
2. Materials and methods 
[2-14C]folic acid (PGA, 55.3 pCi/pmoles) was pur- 
chased from the Radiochemical Centre (Amersham, 
Bucks). Sepharose-4B was a product of Pharmacia 
(Uppsala, Sweden). Cyanogen bromide was obtained 
from Eastman Organic Chemicals (Rochester, New 
York). Radioactivity was determined as described 
earlier [lo] . 
2.1.Preparation offolate-bindingprotein fromgoat’s 
milk 
Goat’s milk was used as it contains 2 to 4-fold more 
folate binder than cow’s milk. The protein was puri- 
fied by a procedure similar to the one described by 
Salter et al. [6] , however, instead of folate-bound 
Sepharose, methotrexate bound to Sepharose was 
used to bind the protein. The protein was released 
from the column by acetic acid (0.2 M) instead of 
urea. Details of the purification procedure will be pub- 
lished elsewhere. The purified protein was concen- 
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trated by lyophilization and the acetic acid was neu- 
tralized with NaOH prior to its addition to the acti- 
vated Sepharose. 
2.2. Activation of Sepharose and f’vcation of the 
folate-binding protein 
Sepharose4B (5 ml bed volume) was washed with 
distilled water and activated in a 50% suspension with 
1 g cyanogen bromide at pH 11 [ 111. After washing 
with cold NaHC03 (0.1 M, 300 ml) and resuspending 
in 5 ml of the NaHC03 solution, the binding protein 
(2 ml, containing 7 mg protein with a total binding 
capacity of 66 000 ng of PGA) was added, and the 
pH adjusted to 8.5. The mixture was stirred for 4 hr 
in an ice bath under a stream of N2; it was then 
packed into a column and washed at a rate of 4 
ml/mm for 48 hr with 1 M NaCl containing 0.1 M 
potassium phosphate buffer (pH 7.0). The Sepharose 
was then suspended in water to a final volume of 9 
ml. 
3. Results 
Table 1 and 2 show the conditions for binding of 
radio-PGA to the Sepharose-protein complex and 
for releasing of the vitamin from the column. In con- 
trast to the soluble binder, from which PGA can be 
released by acetic acid, a stronger acid (HCl) was re- 
quired to release the vitamin from the Sepharose- 
bound binder. Treatment with HCl released the PGA 
without affecting the binding ability of the subse- 
quently regenerated column (table 3). 
To determine the capacity of the insoluble protein- 
binder, radioactive PGA was loaded in 100 ng aliquots 
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Table 1 
Binding of radio-folic acid to the protein-Sepharose complex. 
Fraction no Elution conditions Fraction volume Radioactivity eluted 
(ml) % 
Effluent 
0.1 M phosphate (pH 7.0) 
0.1 M phosphate (pH 7.0) containing NaCl 1 M 
0.1 M phosphate (pH 7.0) containing NaCl 1 M 
0.1 M phosphate (pH 7.0) containing NaCl 1 M 
0.1 M acetic acid 
0.1 M acetic acid 
0.1 M acetic acid 
Like no 2 but heating column content for 2 min at 100°C 
2 
2 
2 
2 
10 
2 
2 
2 
3 
1.0 
0.8 
0.5 
0 
0 
7.2 
2.0 
0 
54 
The protein-Sepharose complex was packed into a Pasteur pipette (0.3 ml bed volume) and washed with 10 ml 1 M potassium 
phosphate buffer (pH 7.0). Radio-folic acid (20 000 cpm) in 2 ml 0.1 M potassium phosphate buffer (pH 7.0) was applied onto 
the column. Elution was attempted, using different conditions as given in the table. 
on a column, which was prepared from 0.15 ml of the 
Sepharose-binder complex suspension. After each ad- 
dition and appropriate washing, the amount of folate 
bound in the effluent was subtracted from that added, 
to obtain the bound PGA (fig. 1). At saturation 600 
ng of folate was bound (table 4), thus the whole sus- 
pension of the protein-Sepharose complex (9 ml) 
was able to bind 36 000 ng FGA which corresponded 
to 54% of the original activity. 
Table 2 
Effect of acids on the release of radio-folic acid from the 
Sepharose-protein complex. 
Fraction Fraction Radioactivity 
no Elution conditions volume eluted 
(ml) % 
1 Effluent 2 7.5 
2 0.1 M phosphate (pH 7.0) 2 2.5 
3 0.2 M acetic acid 2 11.5 
4 0.2 M acetic acid 2 2.5 
5 0.1 M HCI 2 73 
6 0.1 M HCl 2 3 
Protein-Sepharose complex (0.1 ml bed volum$) was packed 
into a column with non-activated Sepharose-4B (0.5 ml bed 
volume) and washed with 0.1 M potassium phosphate buffer 
pH 7.0 (10 ml). Radiofolic acid (20 000 cpm) was added to 
the column. After washing with phosphate buffer to remove 
unbound folate, the column was washed with acids as de- 
scribed in the table. 
*Non-activated Sepharose4B was employed to increase the 
bed volume. 
4. Discussion 
According to Goldstein [ 121, proteins bound to 
water-insoluble polymers are suitable for repeated 
and continuous use since they are usually stable and 
they do not contaminate the reaction products; they 
can also be employed for the adsorption and puritka- 
tion of inhibitors of the activities of these proteins. 
The insoluble folatebmding protein described above 
also shows these properties. The rapidity by which 
FGA is absorbed to, and desorbed from, the column 
and the regeneration of the column renders the prep 
aration suitable for purification of folates. The meth- 
od can also be applied to remove ndogenous folates 
Table 3 
Binding of radio-folic acid to a regenerated Sepharose-pro- 
tein complex. 
Fraction Fraction Radioactivity 
no Elution conditions volume eluted 
(ml) % 
1 Effluent 2 8.6 
2 0.1 M phosphate (pH 7.0) 2 1.8 
3 0.1 M HCl 2 69 
4 0.1 M HCl 2 8 
The column employed in table 2 was washed with 0.1 M phos- 
phate buffer pH 7.0 till the pH of the effluent was neutral. 
Radioactive folk acid (20 000 cpm) was applied to the col- 
umn and then eluted as described in the table. 
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Fig. 1. Determination of folate-binding capacity of the pro- 
tein-Sepharose complex. Protein-Sepharose complex, (0.15 
ml suspension, 0.075 ml bed volume) was packed with non- 
activated Sepharose-4B (0.8 ml bed volume) into a Pasteur 
pipette column. The column was then washed sequentially 
with 5 ml 0.1 M HCl, 5 ml 1 M potassium phosphate buffer 
(pH 7.0) and finally with 5 ml 0.1 M phosphate buffer (pH 
7.0). Aliquots (0.25 ml) of radio-folic acid (400 ng/ml) were 
applied repeatedly to the column followed by washing each 
time with 2.75 ml 0.1 M potassium phosphate buffer (pH 7.0). 
The effluent was assayed for radioactivity. The difference in 
values between added and eluted radioactivity represents the 
measure of bound folate. Addition of radio-folate was discon- 
tinued when the above difference approached zero. 
from enzymatic reactions in which folate is involved 
as a coenzyme. The column can also be used to mea- 
sure the transfer of one carbon unit to or from tetra- 
hydrofolates. We are currently investigating the feasi- 
bility of using this column for folate radioassay. 
Table 4 
Comparison between calculated and eluted bound radio-folate 
at saturation*. 
cpm 
Calculated 132 580 
Found after elution with 0.1 M HCl 133 000 
* Details of this experiment are given in fig. 1. 
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